V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006081 | 280003769 | 1.82 | 90 | Adjuvant (A) | 2017-06-01 | 2017-06-02 | Doxorubicin + Olaratumab | 2 | N | 280030237 | DE-ESCALATE TRIAL |
| 280006082 | 280003770 | 1.68 | 61.6 | Palliative (P) | 2014-11-16 | 2014-11-29 | Epirubicin | 2 | N | 280030241 | IVA |
| 280006083 | 280003770 | 0 | 78.4 | Palliative (P) | 2013-03-07 | 2013-03-07 | Imatinib 400mg | 02 | N | 280030241 | TRABECTEDIN |
| 280006084 | 280003770 | null | 79.1 | Palliative (P) | 2015-02-16 | 2015-03-05 | ECX | N | N | 280030241 | KESTREL TRIAL |
| 280006085 | 280003770 | 1.72 | 149 | Curative (C) | 2015-09-18 | 2015-09-18 | ECX | N | N | 280030241 | COMPARE TRIAL |
| 280006086 | 280003771 | 1.7 | 69 | Adjuvant (A) | 2017-04-25 | 2017-04-25 | VIDE | null | null | 280030252 | OXALIPLATIN + MDG |
| 280006087 | 280008044 | 1.8 | 59.95 | Palliative (P) | 2018-09-17 | 2018-09-19 | CARBOPLATIN + GEMCITABINE | Y | Y | 280030256 | CARBO + FLUOROURACIL |
| 280006088 | 280008044 | 1.69 | 61.4 | Disease modification (D) | null | 2018-03-04 | LANREOTIDE | null | null | 280030256 | TCF |
| 280006089 | 280003772 | 0 | null | null | 2016-09-01 | 2016-09-28 | Carboplatin + Pemetrexed | 2 | Y | 280030259 | VIDE |
| 280006090 | 280003773 | 1.73 | 60.35 | null | 2014-09-22 | 2014-10-14 | ECX | null | N | 280030260 | IFOSFAMIDE |
| 280006091 | 280003773 | 1.8 | 65 | Neo-adjuvant (N) | null | 2013-09-15 | Cisplatin + Doxorubicin | N | N | 280030260 | MAP |
| 280006092 | 280003774 | 1.68 | 59.3 | Palliative (P) | 2016-09-24 | 2016-09-24 | Doxorubicin + Olaratumab | 01 | Y | 280030262 | CVD |
| 280006093 | 280003775 | 1.56 | 47 | null | 2016-11-26 | 2016-12-14 | Cisplatin + Fluorouracil + RT 5day | 99 | null | 280030264 | FLUOROURACIL + MITOMYCIN + RT |
| 280006094 | 280003775 | 0.84 | null | null | null | 2014-08-23 | Paclitaxel 7 day | null | null | 280030264 | FLUOROURACIL + MITOMYCIN + RT |
| 280006095 | 280003776 | 1.7 | 89.2 | Adjuvant (A) | null | 2017-10-16 | Erlotinib | null | null | 280030266 | TRABECTEDIN |
| 280006096 | 280003777 | 1.6 | 64.3 | Palliative (P) | 2017-08-21 | 2017-08-21 | PEMBROLIZUMAB | Y | null | 280030267 | PACLITAXEL |
| 280006097 | 280003777 | 1.83 | 46.4 | Palliative (P) | 2016-05-20 | 2016-05-27 | DE-ESCALATE TRIAL | N | N | 280030267 | DOXORUBICIN + OLARATUMAB |
| 280006098 | 280003778 | 1.62 | 91.2 | Neo-adjuvant (N) | null | 2015-10-21 | Cisplatin + Fluorouracil + RT 5day | N | N | 280030273 | EURO-EWING |
| 280006099 | 280008048 | 1.79 | 71.7 | null | 2017-04-14 | 2017-05-26 | DE-ESCALATE TRIAL | N | N | 280030274 | CAPECITABINE + GEMCITABINE |
| 280006100 | 280003779 | 1.72 | null | Curative (C) | 2014-11-24 | 2014-11-29 | IVADo | N | N | 280030275 | DARS TRIAL |
| 280006101 | 280008049 | null | null | Curative (C) | 2016-11-23 | 2016-12-21 | Paclitaxel 7 day | Y | Y | 280030277 | PAZOPANIB |
| 280006102 | 280008049 | 1.59 | 80.3 | Palliative (P) | 2016-05-26 | 2016-05-31 | Irinotecan + Modified De Gramont | 2 | N | 280030277 | IPILIMUMAB |
| 280006103 | 280003780 | 1.62 | 62.1 | Palliative (P) | 2013-07-26 | 2013-08-23 | ECX | N | Y | 280030280 | VIDE |
| 280006104 | 280003781 | 1.82 | 76 | null | 2013-10-16 | 2013-11-06 | Cetuximab + CISPLATIN | N | N | 280030281 | CARBOPLATIN + PACLITAXEL + RT |
| 280006105 | 280003781 | null | 87.55 | Palliative (P) | null | 2016-03-15 | Docetaxel + Gemcitabine with GCSF | null | null | 280030281 | TRABECTEDIN |
| 280006109 | 280003783 | 1.8 | 71.8 | Adjuvant (A) | 2014-05-08 | 2014-05-09 | EW EuroEwing 99 : VIDE | 01 | N | 280030287 | TRABECTEDIN |
| 280006110 | 280003783 | 1.7 | 75.5 | Palliative (P) | 2015-05-14 | 2015-06-08 | FCarboSt | N | Y | 280030287 | CARBOPLATIN + PEMETREXED |
| 280006111 | 280003783 | 1.8 | 106.9 | Palliative (P) | 2017-11-21 | 2017-12-06 | VAC | N | N | 280030287 | CAPECITABINE + CISPLATIN |
| 280006112 | 280003784 | null | 61.15 | Palliative (P) | 2017-01-20 | 2017-02-09 | Bevacizumab + Capecitabine | N | N | 280030291 | DOXORUBICIN + OLARATUMAB |
| 280006113 | 280003784 | 1.66 | 60.9 | Palliative (P) | 2016-03-24 | 2016-03-28 | Pazopanib | N | N | 280030291 | PACLITAXEL |
| 280006114 | 280003785 | null | null | Palliative (P) | 2016-02-23 | 2016-02-26 | FCiSt | N | N | 280030293 | CETUXIMAB + CISPLATIN + FU |
| 280006115 | 280003785 | 1.73 | 75.9 | Curative (C) | 2016-06-24 | 2016-07-05 | PEMBROLIZUMAB | N | N | 280030293 | DE-ESCALATE TRIAL |
| 280006116 | 280003786 | 1.58 | 109.9 | Palliative (P) | null | 2013-05-15 | CARBOPLATIN + GEMCITABINE | N | N | 280030298 | PACLITAXEL |
| 280006117 | 280008055 | 1.81 | 89 | null | 2017-03-26 | 2017-04-09 | Sunitinib | N | N | 280030300 | VIDE |
| 280006118 | 280003787 | 1.8 | 80.6 | Disease modification (D) | 2017-04-16 | 2017-04-16 | TCF | Y | Y | 280030301 | PACLITAXEL |
| 280006119 | 280003787 | 1.74 | 72.15 | Neo-adjuvant (N) | 2014-07-06 | 2014-07-11 | Carboplatin + Pemetrexed | 02 | N | 280030301 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280006120 | 280003787 | 1.68 | 93.6 | Palliative (P) | 2018-01-18 | 2018-02-13 | EW EuroEwing 2012 Arm A VIDE | 01 | Y | 280030301 | DOXORUBICIN + OLARATUMAB |
| 280006123 | 280003789 | 0 | 0 | Adjuvant (A) | 2017-03-27 | 2017-04-16 | Oxaliplatin + Modified de Gramont | N | N | 280030312 | CARBO + FLUOROURACIL |
| 280006124 | 280003790 | 1.75 | 0 | Curative (C) | 2017-05-25 | 2017-05-25 | Carboplatin + Cetux + FU (>Cycle 2) | null | N | 280030313 | CAPECITABINE + CISPLATIN + RT |
| 280006125 | 280003790 | 1.71 | 83 | Palliative (P) | 2014-12-20 | 2014-12-20 | Capecitabine + Cisplatin | 02 | N | 280030313 | TEMOZOLOMIDE |
| 280006126 | 280010090 | 1.54 | null | null | 2017-01-27 | 2017-01-27 | Paclitaxel 7 day | N | N | 280030318 | CISPLATIN + DOXORUBICIN |
| 280006127 | 280003791 | 1.6 | 87.5 | Curative (C) | 2013-03-07 | 2013-03-31 | Capecitabine + Oxaliplatin 21day | N | N | 280030319 | CISPLATIN + FLUOROURACIL + RT |
| 280006128 | 280003791 | null | null | Curative (C) | 2013-06-21 | 2013-08-24 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 280030319 | EURO-EWING |
| 280006129 | 280003792 | 1.71 | 99 | Neo-adjuvant (N) | 2015-10-17 | 2015-11-04 | LANREOTIDE | N | N | 280030324 | ETOPOSIDE + IFOSFAMIDE |
| 280006130 | 280003793 | 1.54 | 108.65 | Palliative (P) | null | 2015-01-28 | Ifosfamide | null | null | 280030328 | CAPECITABINE + CARBOPLATIN |
| 280006131 | 280003793 | 1.7 | 85.1 | Adjuvant (A) | 2017-04-30 | 2017-05-04 | CAPECITABINE + MITOMYCIN + RT | N | N | 280030328 | CISPLATIN + DOXORUBICIN |
| 280006132 | 280003794 | 1.72 | 87.1 | Neo-adjuvant (N) | 2014-06-04 | 2014-06-21 | ECX | 1 | N | 280030330 | EURO-EWING |
| 280006133 | 280003794 | 1.8 | 53.3 | Neo-adjuvant (N) | 2014-02-12 | 2014-02-12 | Abiraterone | 2 | N | 280030330 | EURO-EWING |
| 280006134 | 280010091 | 1.61 | 31.45 | null | 2015-09-27 | 2015-10-19 | STS Rhabdo Rel BERNIE IVADo | N | N | 280030335 | VIDE |
| 280006135 | 280010091 | 1.6 | 40.5 | Neo-adjuvant (N) | 2014-02-28 | 2014-03-14 | Ifosfamide PVI 1g/m2 14day | 2 | N | 280030335 | BCG |